tiprankstipranks
Advertisement
Advertisement

BTAI Stock Latest News

BioXcel Therapeutics Amends Credit Agreement, Eases Liquidity Terms
Company AnnouncementsBioXcel Therapeutics Amends Credit Agreement, Eases Liquidity Terms
4d ago
8K
BTAI
Is BTAI a Buy, Before Earnings?
PremiumPre-Earnings
Is BTAI a Buy, Before Earnings?
6d ago
BTAI
BioXcel’s BXCL501 Agitation Study Completion: What Investors Should Watch Next
PremiumCompany Announcements
BioXcel’s BXCL501 Agitation Study Completion: What Investors Should Watch Next
9d ago
BTAI
BioXcel Therapeutics Amends Credit Agreement, Extends Debt Deadline
PremiumCompany Announcements
BioXcel Therapeutics Amends Credit Agreement, Extends Debt Deadline
12d ago
8K
BTAI
BioXcel Therapeutics Amends Credit Agreement, Tightens Liquidity
PremiumCompany Announcements
BioXcel Therapeutics Amends Credit Agreement, Tightens Liquidity
1M ago
8K
BTAI
BioXcel Therapeutics reports Q1 EPS (54c), consensus (49c)
PremiumThe FlyBioXcel Therapeutics reports Q1 EPS (54c), consensus (49c)
3M ago
BTAI
Bioxcel Issues Warrants in Private Equity Financing Deal
Premium
Company Announcements
Bioxcel Issues Warrants in Private Equity Financing Deal
4M ago
8K
BTAI
BioXcel Therapeutics enrolls first patients in BXCL501 trial
Premium
The Fly
BioXcel Therapeutics enrolls first patients in BXCL501 trial
4M ago
BTAI
BioXcel Therapeutics: Undervalued Franchise with IGALMI PDUFA Catalyst Supports Buy Rating Despite Reduced Target
PremiumRatings
BioXcel Therapeutics: Undervalued Franchise with IGALMI PDUFA Catalyst Supports Buy Rating Despite Reduced Target
5M ago
BTAI
BioXcel Therapeutics price target lowered to $5 from $6 at H.C. Wainwright
PremiumThe Fly
BioXcel Therapeutics price target lowered to $5 from $6 at H.C. Wainwright
5M ago
BTAI
FDA Accepts BioXcel sNDA for At-Home IGALMI Use
PremiumCompany Announcements
FDA Accepts BioXcel sNDA for At-Home IGALMI Use
5M ago
8K
BTAI
BioXcel Therapeutics announces FDA acceptance of Igalmi sNDA
PremiumThe Fly
BioXcel Therapeutics announces FDA acceptance of Igalmi sNDA
5M ago
BTAI
Morning Movers: AstraZeneca jumps following tozorakimab trial results
PremiumThe FlyMorning Movers: AstraZeneca jumps following tozorakimab trial results
5M ago
AGX
AZN
BioXcel Therapeutics reports Q4 EPS (58c), consensus (63c)
Premium
The Fly
BioXcel Therapeutics reports Q4 EPS (58c), consensus (63c)
5M ago
BTAI
BioXcel Therapeutics initiated with a Buy at Rodman & Renshaw
Premium
The Fly
BioXcel Therapeutics initiated with a Buy at Rodman & Renshaw
5M ago
BTAI
BioXcel Therapeutics Announces Registered Direct Equity Financing
PremiumCompany Announcements
BioXcel Therapeutics Announces Registered Direct Equity Financing
5M ago
8K
BTAI
BioXcel price target lowered to $6 from $10 at H.C. Wainwright
PremiumThe Fly
BioXcel price target lowered to $6 from $10 at H.C. Wainwright
5M ago
BTAI
BioXcel Therapeutics announces results from Phase 2 trial of BXCL501
PremiumThe Fly
BioXcel Therapeutics announces results from Phase 2 trial of BXCL501
5M ago
BTAI
BioXcel Therapeutics announces results from Phase 2 trial of BXCL501
PremiumThe Fly
BioXcel Therapeutics announces results from Phase 2 trial of BXCL501
5M ago
BTAI
BTAI Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsBTAI Upcoming Earnings Report: What to Expect?
6M ago
BTAI
BioXcel Therapeutics to host KOL roundtable on Alzheimer’s dementia
Premium
The Fly
BioXcel Therapeutics to host KOL roundtable on Alzheimer’s dementia
6M ago
BTAI
BioXcel Highlights IGALMI At-Home Acute Agitation Opportunity
Premium
Company Announcements
BioXcel Highlights IGALMI At-Home Acute Agitation Opportunity
6M ago
8K
BTAI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >